Monday, 9 November 2026European Markets

ECB Policy

5 articles

ECB Tightens as Fed Holds: Rate Divergence Reshapes European Markets

ECB Tightens as Fed Holds: Rate Divergence Reshapes European Markets

The ECB is tightening monetary policy while the newly appointed Fed Chair Kevin Warsh holds U.S. rates amid three-year-high inflation. Home furnishings import tariffs have doubled since Q1 2025, compounding the Fed's dilemma and widening the transatlantic policy gap. European capital markets are repricing as the Bank of Japan simultaneously prepares its own rate increases, creating a three-way monetary divergence with no modern precedent.

LM Salvado•
ECB Signals June Rate Hike as Inflation Risks Worsen, Diverging from Frozen Fed

ECB Signals June Rate Hike as Inflation Risks Worsen, Diverging from Frozen Fed

ECB Governing Council member Christodoulos Patsalides has warned that eurozone inflation risks are worsening, signalling a June rate hike. The move would sharpen a transatlantic policy split: markets now price only a one-in-three chance of any Fed cut in 2026. The divergence is reshaping the euro's trajectory and repricing rate-sensitive European assets.

LM Salvado•
ECB Delays Rate Decision Until June as Iran Crisis Eases Inflation Pressure

ECB Delays Rate Decision Until June as Iran Crisis Eases Inflation Pressure

The European Central Bank is postponing interest rate decisions until June to assess whether the Iran crisis oil shock is temporary or persistent. ECB officials signal patience after Iran reopened the Strait of Hormuz on April 18, causing WTI crude to plunge 11% and validating their wait-and-see approach.

LM Salvado•
ECB Joins Global Rate Pause as Inflation Resilience Trumps Growth Concerns

ECB Joins Global Rate Pause as Inflation Resilience Trumps Growth Concerns

The European Central Bank is holding rates steady in March 2026 alongside the Federal Reserve, Bank of Russia, and Brazil's central bank. Former Cleveland Fed President Loretta Mester signals central banks will maintain restrictive policy until inflation convincingly moves toward 2% targets. The coordinated pause marks a shift from earlier easing expectations as policymakers navigate persistent inflation and geopolitical risks.

ViaNews Editorial Team (Europe)•
ECB Signals Continued Easing as Fed Independence Concerns Cloud Global Policy Outlook

ECB Signals Continued Easing as Fed Independence Concerns Cloud Global Policy Outlook

The European Central Bank is maintaining its cautious easing trajectory as inflation pressures subside, with policymaker Joachim Nagel describing the euro area's inflation picture as favorable. Meanwhile, concerns about Federal Reserve independence ahead of Jerome Powell's May 2026 term expiration are creating market uncertainty, as analysts warn of potential political pressure from the Trump administration.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com